摘要
目的分析应用天麻素注射液治疗神经衰弱的临床效果以及安全性。方法随机收集2014年1月—2015年1月期间该院收治的66例神经衰弱患者作为研究对象,随机将其分成对照组以及研究组,研究组选择天麻素注射液治疗,而对照组选择常规方法治疗,对两组患者的临床疗效进行分析。结果对照组患者的总有效率为78.79%,研究组患者的总有效率为93.94%,其中研究组患者的临床疗效显著优于对照组,两组数据进行比较,差异有统计学意义(P<0.05)。结论应用天麻素注射液治疗神经衰弱,具备较好的临床效果,可以使患者神经衰弱的临床症状得到缓解,并使患者的睡眠质量以及临床效果得到提升,在临床中值得广泛推广应用。
Objective To investigate the clinical effect and safety of gastrodin injection in treating neurasthenia. Methods 66 cases with neurasthenia in our hospital from January 2014 to January 2015 were selected. They were divided into control group and observation group randomly. The observation group was given gastrodin injection and control group was given conventional treatment. Analyzed the clinical effect of the two groups. Results Compared and analyzed the clinical effect of the two groups, the total efficiency of control group was 78.79%, and that of observation group was 93.94%. Clinical effect of observation group was better than control group, the difference was statistically significant(P <0.05). Conclusion Gastrodin injection in treating neurasthenia has better clinical effect. It can relieve neurasthenia and improve sleep quality and clinical effect. It is worthy of wide application.
出处
《中国卫生产业》
2015年第21期68-69,共2页
China Health Industry